FLEX:NASDAQFlex Ltd. Analysis
Data as of 2026-05-19 - not real-time
$127.33
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Flex Ltd. is trading at $127.33, comfortably above its 20‑day ($114.01), 50‑day ($87.55) and 200‑day ($67.09) simple moving averages, signaling a strong upward bias. The MACD line (15.48) sits above its signal (15.16) with a positive histogram, and the RSI at 63.9 indicates momentum without extreme overbought conditions. Volume is on an increasing trend, and the overall technical outlook is bullish, reinforced by recent earnings that beat expectations and news of a spin‑off of its cloud and power infrastructure business, which has sparked a six‑session winning streak.
On the valuation side, the stock appears stretched: a trailing P/E of 54.6 versus an industry average of 38.2, and a DCF‑derived fair value of $61 contrast sharply with the current price, suggesting overvaluation. Forward P/E collapses to 18.8, supported by a 16.9% revenue growth rate and a projected EPS jump to $6.79, implying a potential upside of ~25% but also exposing investors to high volatility (30‑day volatility ~106%) and a lofty beta of 2.44. The company carries no dividend, has a high debt‑to‑equity ratio, and operates in a cyclical technology segment, all of which temper the bullish technical picture.
On the valuation side, the stock appears stretched: a trailing P/E of 54.6 versus an industry average of 38.2, and a DCF‑derived fair value of $61 contrast sharply with the current price, suggesting overvaluation. Forward P/E collapses to 18.8, supported by a 16.9% revenue growth rate and a projected EPS jump to $6.79, implying a potential upside of ~25% but also exposing investors to high volatility (30‑day volatility ~106%) and a lofty beta of 2.44. The company carries no dividend, has a high debt‑to‑equity ratio, and operates in a cyclical technology segment, all of which temper the bullish technical picture.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (price above SMAs, bullish MACD, supportive RSI)
- Recent earnings beat and positive spin‑off news driving momentum
- Increasing volume and strong intraday price performance
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward earnings growth (forward P/E 18.8) offering upside potential
- Current price significantly above DCF fair value and trailing P/E
- High volatility and beta indicating price swings
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Diversified exposure to high‑growth tech and industrial segments
- Valuation compression risk given overvalued metrics
- Strong cash flow generation but elevated debt levels
Key Metrics & Analysis
Financial Health
Revenue Growth16.90%
Profit Margin3.17%
P/E Ratio54.6
ROE16.85%
ROA4.53%
Debt/Equity83.90
P/B Ratio9.1
Op. Cash Flow$1.7B
Free Cash Flow$934.5M
Industry P/E38.2
Technical Analysis
TrendBullish
RSI63.9
Support$83.97
Resistance$147.34
MA 20$114.01
MA 50$87.55
MA 200$67.09
MACDBullish
VolumeIncreasing
Fear & Greed Index89.7
Valuation
Fair Value$61.00
Target Price$159.00
Upside/Downside24.87%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.44
Volatility105.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.